Patients with a SULFA allergy should not take MIC B12 injections due to the methionine component [2]
AOD-9604 Safety Profile and Potential Side Effects Safety data from over 900 clinical trial participants provides comprehensive information about AOD-9604s tolerability, side effect profile, and important contraindications
Our guess is that you havent tried this one
Hypercobalaminaemia is usually asymptomatic and discovered incidentally during blood tests
Many women say they feel more energized, happier, able to concentrate better, and notice more effective fat-burning while exercising or managing a full schedule
not primarily appetite-driven (OUP Academic) Expected weight loss (this is where many people get misled) In major obesity trials: Semaglutide 2.4 mg weekly: ~14.9% mean weight loss at 68 weeks (STEP-1) (PubMed) Tirzepatide: ~15.0% to ~20.9% mean weight loss at 72 weeks , dose-dependent (SURMOUNT-1) (PubMed) AOD-9604s best-known human signal is kilograms, not double-digit percentages , and later studies did not sustain a strong obesity-drug profile